Cagney Michael Scott

Director Cagney Michael Scott liquidates full 35.2K share position at FIGR via 6 sales totaling $1.3M under 10b5-1 plan

Cagney Michael Scott, a director, sold 6 separate tranches totaling 35,190 shares for $1,344,274.05 on 2026-05-13, reducing his holdings to zero shares. The sales were executed across a range of prices ($35.68 to $40.47 per share) and represent a complete exit from his position. This transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-12-12, making it a scheduled transaction rather than a discretionary trade. The stock is currently trading at $43.28, within its 52-week range of $25.01–$78.00. Investors should note that the complete liquidation removes an insider stake while the company reports strong fundamentals: $167.0M quarterly revenue with +48.7% annual growth and $44.9M net income, though the stock carries a high P/E of 80.15.

Director Cagney Michael Scott sells 67.8K shares for $2.4M ($35.19 avg) via 3 transactions; exits position entirely via conversion

Director Cagney Michael Scott executed 3 separate sales totaling 67,840 shares for $2,387,554.12 on April 15, 2026, at blended average price $35.19, reducing his holdings to 0 shares post-transaction. This filing involves a derivative-conversion transaction where the position shift is documented in Table II derivative securities rather than a discretionary open-market exit. The stock currently trades at $36.67, up 8.9% over 30 days but down 50.4% from its 52-week high of $73.91. At the same ticker (FIGR), Scott's prior 5 trades show 4 of 5 were well-timed at the 90-day mark, though the recent 90-day returns on his December 2025 and November 2025 sales ranged from -0.1% to +2.3%, indicating mixed results in the immediate prior period. The company's fundamentals remain solid with $156.4M quarterly revenue and strong 48.7% annual revenue growth, though the P/E of 67.91 reflects high valuation expectations.

Director Cagney Michael Scott sold 200,058 shares for $7,881,711.22 across 3 transactions on 2025-12-10.

Director Cagney Michael Scott executed 3 separate sales totaling 200,058 shares for $7,881,711.22 at a blended average price of $39.40 on 2025-12-10, reducing holdings to zero shares in open-market Form 4 position. The sales span a narrow price range from $38.69 to $40.08, executed within a single trading day. The timing occurs within a window of elevated stock performance: the 30-day change shows +10.3% and the 90-day change shows +26.6%, though current price of $41.16 is 16.3% below the 52-week high of $49.17. Notably, a FLAG indicates this filing involves a conversion (C) of derivative securities, and the insider's complete real position may include Form 4 Table II derivative holdings not yet populated in the database; the Form 4 Table I shares_after figure of zero does not necessarily represent the insider's total economic position. The company's financial profile shows revenue of $156,365,000.00 and net income of $89,576,000.00 in the latest quarter.

Director Cagney Michael Scott sold 750,000 shares for $26.6M across 8 transactions (Nov 20–21), reducing stake by 10.9%

Cagney Michael Scott (Director) executed 8 separate sales totaling 750,000 shares for $26,624,025.87 at a blended average price of $35.50 on November 20–21, 2025. The sale reduces his holdings from 6,878,993 shares to 6,128,993 shares, a net reduction of 10.9%. The transactions occurred while the stock is trading at $35.77, only 27.2% below its 52-week high of $49.17 and up significantly from the 52-week low of $31.11, yet down 10.5% over the past 30 days. The company posted revenue of $156,365,000 and net income of $89,576,000 in the latest quarter. Scott's cross-ticker track record shows 1 prior open-market sale with a 30-day return of +69.0%; his single prior sale at Figure (Sept 2025) also showed a 30-day return of +69.0%, though 90-day outcome data is not yet available. The scale of this divestiture—representing 10.9% of his pre-transaction stake—warrants attention to whether this reflects portfolio adjustment or other material considerations affecting the company.

Director Cagney Michael Scott sold 1,500,000 shares of FIGR at $25.00 for $37,500,000.00; conversion of derivative securities.

Director Cagney Michael Scott converted and sold 1,500,000 shares at $25.00 on 2025-09-12, two trading days after FIGR's public listing. This represents a conversion of derivative securities (likely stock options or warrants) into common shares immediately followed by a sale. The $25.00 transaction price sits $7.50 below the current market price of $32.50, indicating the underlying derivative was granted at or exercised at a substantial discount to current valuations. As a derivative-conversion transaction, Scott retains additional derivative positions not yet visible in the Form 4 Table II data; this is not a complete position exit. The large dollar value ($37,500,000.00) and immediate exercise-and-sale pattern in a newly public company warrant scrutiny into the terms of the original derivative grant and exercise mechanics.